COMMUNIQUÉS West-GlobeNewswire

Xeris Pharmaceuticals Announces Second Quarter 2019 Financial Results and Highlights
06/08/2019
CHICAGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use [...]
VIVUS Reports Second Quarter 2019 Financial Results
06/08/2019
Company to host conference call today at 4:30pm ET CAMPBELL, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ: VVUS) (the “Company”), a specialty pharmaceutical company committed to the development and [...]
SI-BONE, Inc. Reports Second Quarter 2019 Financial Results
06/08/2019
SANTA CLARA, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results [...]
WW Announces Second Quarter 2019 Results and Raises Full Year 2019 EPS Guidance
06/08/2019
End of Period Subscribers in Q2 2019 of 4.6 million Revenues in Q2 2019 of $369 million Q2 2019 EPS of $0.78 Raising FY 2019 EPS guidance to a range of $1.55 to $1.70 NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Weight [...]
vTv Therapeutics to Participate in Upcoming Canaccord Genuity and Solebury Trout Conferences
06/08/2019
HIGH POINT, N.C., Aug. 06, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered treatments for [...]
Akcea Reports Financial Results and Highlights for Second Quarter 2019
06/08/2019
Achieved Second Quarter 2019 TEGSEDI ® (inotersen) Global Net Product Revenues of $10 Million Conference Call Webcast Tuesday, August 6, 4:30 p.m. ET at www.akceatx.com BOSTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Akcea [...]
Chembio Diagnostics Reports Second Quarter 2019 Financial Results
06/08/2019
MEDFORD, N.Y., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter [...]
Paratek Pharmaceuticals Generates Net Revenues of $2.0 Million in the Second Quarter of 2019
06/08/2019
-- NUZYRA ® (omadacycline) Net Sales increased 26% to $1.7 Million in the Second Quarter of 2019 -- -- Over 50% of Commercial Lives in U.S. now have Access to NUZYRA -- -- Paratek Promotes Evan Loh, M.D. to Chief [...]
Codexis Names Ross Taylor Senior Vice President and Chief Financial Officer
06/08/2019
CFO Gordon Sangster announces retirement REDWOOD CITY, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces the appointment of Ross Taylor as Senior [...]
IRIDEX Announces 2019 Second Quarter Financial Results
06/08/2019
MOUNTAIN VIEW, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended June 29, 2019. Second Quarter Highlights Total revenue of $10.4 [...]
Forty Seven Inc. to Report Second Quarter 2019 Financial Results on Tuesday, August 13, 2019
06/08/2019
MENLO PARK, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]
PhaseBio To Report Second Quarter 2019 Financial Results and Recent Corporate Progress on August 13, 2019
06/08/2019
MALVERN, Pa. and SAN DIEGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies [...]
Zogenix Provides Corporate Update and Reports Second Quarter 2019 Financial Results
06/08/2019
Agreement reached with U.S. FDA for resubmission of NDA for FINTEPLA® for the treatment of Dravet syndrome; resubmission expected in September Enrollment complete for FINTEPLA global Phase 3 trial in Lennox Gastaut [...]
Retrophin Reports Second Quarter 2019 Financial Results
06/08/2019
Top-line results from pivotal Phase 3 FORT Study in PKAN on-track for 3Q 2019 Commercial launch for THIOLA ® EC underway following FDA-approval for the treatment of cystinuria Second quarter revenues increased eight [...]
Editas Medicine Appoints Cynthia Collins as President and Chief Executive Officer
06/08/2019
CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that its Board of Directors has unanimously appointed Cynthia (Cindy) Collins, [...]
Axogen, Inc. Reports 2019 Second Quarter Financial Results
06/08/2019
Second Quarter Revenue of $26.7 million, Representing 30% Growth Versus Second Quarter 2018 ALACHUA, Fla., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing [...]
Cambrex to Announce Second Quarter 2019 Financial Results on August 9, 2019
06/08/2019
EAST RUTHERFORD, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
The Spanish Sarcoma Group Will Lead a European Consortium to Evaluate the Ability of Lixte Biotechnology Holdings’ LB-100 to Improve First Line Therapy for Advanced Soft Tissue Sarcomas
06/08/2019
EAST SETAUKET, NY, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. ( OTCQB: LIXT ) announced that it signed a clinical trial agreement with the Spanish Sarcoma Group (Grupo Español de Investigación [...]
The Spanish Sarcoma Group Will Lead a European Consortium to Evaluate the Ability of Lixte Biotechnology Holdings’ LB-100 to Improve First Line Therapy for Advanced Soft Tissue Sarcomas
06/08/2019
EAST SETAUKET, N.Y., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. ( OTCQB: LIXT ) announced that it signed a clinical trial agreement with the Spanish Sarcoma Group (Grupo Español de [...]

Pages